Ad5/3-E2F-d24-GMCSF
AXP000067.1 · Oncolytic virus
- Platform
- adenovirus (Ad5/3 chimera, E2F-1 promoter, Delta-24, GM-CSF-armed)
- Originator
- University of Helsinki (Akseli Hemminki)
Names
| Name | Type | Source |
|---|---|---|
| Ad5/3-E2F-d24-GMCSF | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5/3 chimera
- Replication
- conditionally replicating
- Modifications
- E2F-1 promoter drives E1A; Delta-24; Ad3 fiber knob
- Transgenes
- CSF2
- Route
- intratumoral, intraperitoneal, intrapleural, intravenous
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Notes
ATAP construct (2007-2012). Sometimes given the code CGTG-602; the code was not verified here, so it is not listed as an alias.
How to cite
Ad5/3-E2F-d24-GMCSF (AXP000067.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000067.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.